Author

Annika V. Rademacher

University Hospital Schleswig-Holstein

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

Anke Katharina BergmanniD· 2 shared Gunnar CarioiD· 2 shared Lennart LenkiD· 2 shared Adriana BalduzziiD· 1 shared Aeint-Steffen StröhiD· 1 shared Alina HartmanniD· 1 shared Beat C. BornhauseriD· 1 shared Carmelo RizzariiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Anke Katharina BergmannORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsGenome MedicinePeer-reviewedJul 22, 2026

clinTALL: machine learning-driven multimodal subtypeclassification and treatment outcome prediction in pediatric T-ALL

Lukas Stoiber, Željko Antić, Stefano Rebellato…·Anke Katharina Bergmann

clinTALL is a deep learning framework that classifies pediatric T-ALL subtypes and predicts treatment outcomes using multimodal data, achieving high accuracy and concordance indices.

DOI 10.1186/s13073-026-01733-8

humanwhole-genome sequencing

𝕏 PostBluesky

Cancer BiologyHemaSpherePeer-reviewedFeb 1, 2026

Intra-subtype heterogeneity shapes treatment response in KMT2A-rearranged ALL across all age groups

Alina Hartmann, Lorenz Bastian, Malwine Barz…·Claudia Dorothea Baldus

This study identifies how developmental maturity and fusion partner influence treatment response in KMT2A-rearranged B-ALL across all ages.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky